Leading experts will introduce the audience to recent advances in decoding the specific T cell clonotypes mediating or protecting from disease along with their recognized antigen epitopes in the context of human HLA haplotypes. This information promises to enable next-generation T cell clonotype or epitope targeted immunotherapies for cancer, autoimmune or infectious diseases that are both more efficacious and safer than current therapies. Recent advances in single cell sequencing technologies and large-scale HLA tetramer or HLA reporter gene-based epitope library screening technologies have made decoding the "immune synapse" possible.
FASEB Conferences Diversity Statement:
FASEB is committed to sustaining diversity, equity, accessibility, and inclusion in the biological and biomedical sciences. FASEB’s goal is to create and support a conference environment that is welcoming and safe for all. FASEB believes inclusion of diverse participants, including attendees and speakers, is critical to the scientific and educational integrity of conferences. Organizers are expected to design programs that reflect this commitment. As part of FASEB’s ongoing assessment towards reaching its diversity goals, conference participants are asked to share diversity information. Any data collected from individuals is treated confidentially and used in aggregate format for internal and external review. For more information, please visit https://faseb.org/About-FASEB/Diversity-Equity-and-Inclusion.